IDEXX Laboratories (IDXX) Stock Insights

IDXX price $564.88 +3.63 +0.65%

Ticker
IDXX
Price
$564.88
Change
+3.63 +0.65%
Market cap ?
$44.50B
P/E ?
40.04
Forward P/E ?
38.24
Dividend yield ?
0.00%
Beta ?
1.55
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
53
Value
29
Quality
73
Growth
58

Stocklytics score rationale: value 29, quality 73, growth 58.

Financials

2016201720182019202020212022202320242025
1775423000196905800022132420002406908000270665500032153600003367324000366095300038975040004303702000

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality…

Fair value

IDXX fair value $442.01. Price $564.88. Price is 28% above fair value.

Above fair value, but less expensive than usual. A smaller premium than on 93% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.25B. Growth 15.19%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.5). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 78.78M. Net debt 897.14M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare IDXX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-02—3.72—1.19B
2026-08-044.273.941.22B1.20B
2026-05-053.473.411.14B1.12B
2026-02-023.082.931.09B1.07B
2025-11-033.403.141.11B1.07B
2025-08-043.633.281.11B1.06B
2025-05-012.962.85998.43M997.10M
2025-02-032.622.39954.29M935.15M
2024-10-312.802.68975.54M980.32M
2024-08-063.022.881.00B1.01B
2024-05-012.812.67964.10M964.41M
2024-02-052.322.12901.60M891.25M
2023-11-012.532.37915.53M926.76M
2023-08-012.672.47943.63M934.42M
2023-05-022.552.42900.20M892.47M
2023-02-062.051.94828.57M820.91M
2022-11-012.152.04841.66M830.00M
2022-08-021.561.56860.55M863.14M
2022-05-042.272.26836.55M837.10M
2022-02-021.891.71801.09M781.83M
2021-11-022.031.91810.42M797.10M
2021-07-302.342.02826.14M786.32M
2021-05-042.351.72777.71M740.74M
2021-02-022.011.40720.94M671.24M
2020-10-291.691.43721.79M610.74M
2020-07-311.721.17637.59M433.71M
2020-04-301.291.20626.34M582.64M
2020-01-311.040.90605.45M529.77M
2019-10-311.241.14605.30M556.49M
2019-08-011.431.37620.10M594.08M
2019-05-011.171.05576.06M516.97M
2019-02-010.980.90549.39M504.54M
2018-11-011.050.97545.45M503.85M
2018-08-011.231.17580.75M552.47M
2018-05-041.010.92537.66M495.11M
2018-02-010.770.73506.12M479.81M
2017-10-310.790.74491.98M460.86M
2017-08-010.950.85508.94M455.33M
2017-04-280.770.61462.02M366.00M
2017-02-020.580.51443.00M389.53M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-04Kingsley Lawrence DBuy2.20K$114.17251.52K
2026-09-04Kingsley Lawrence DSell2.20K$532.081.17M
2026-09-04Kingsley Lawrence DSell2.20K$114.17251.52K
2026-08-20Emerson AndrewBuy265$178.2647.24K
2026-08-20Emerson AndrewSell86——
2026-08-20Emerson AndrewSell265$178.2647.24K
2026-07-30HOOLEY JOSEPH LBuy49$558.8027.38K
2026-06-01FENNELL GEORGEBuy639——
2026-06-01FENNELL GEORGESell284$566.79160.97K
2026-06-01FENNELL GEORGESell639——
2026-05-12Vandebroek Sophie V.Buy525$533.92280.31K
2026-05-12Vandebroek Sophie V.Buy234——
2026-05-12SAMAD SAMBuy234——
2026-05-12SAMAD SAMBuy525$533.92280.31K
2026-05-12Peacock KarenBuy525$533.92280.31K
2026-05-12Peacock KarenBuy234——
2026-05-12Kingsley Lawrence DBuy525$533.92280.31K
2026-05-12Kingsley Lawrence DBuy234——
2026-05-12Kingsley Lawrence DBuy168$533.9289.70K
2026-05-12Kingsley Lawrence DBuy75——
2026-05-12JUNIUS DANIEL MBuy525$533.92280.31K
2026-05-12JUNIUS DANIEL MBuy234——
2026-05-12HOOLEY JOSEPH LBuy525$533.92280.31K
2026-05-12HOOLEY JOSEPH LBuy234——
2026-05-12ESSIG STUARTBuy525$533.92280.31K
2026-05-12ESSIG STUARTBuy234——
2026-05-12Claflin Bruce L.Buy234——
2026-05-12Claflin Bruce L.Buy525$533.92280.31K
2026-05-12Britt Irene ChangBuy234——
2026-05-12Britt Irene ChangBuy525$533.92280.31K
2026-05-07Vandebroek Sophie V.Buy257——
2026-05-07Vandebroek Sophie V.Sell257——
2026-05-07SZOSTAK M ANNEBuy257——
2026-05-07SZOSTAK M ANNESell257——
2026-05-07Peacock KarenBuy101——
2026-05-07Peacock KarenSell101——
2026-05-07Kingsley Lawrence DBuy82——
2026-05-07Kingsley Lawrence DBuy257——
2026-05-07Kingsley Lawrence DSell82——
2026-05-07JUNIUS DANIEL MBuy257——
2026-05-07JUNIUS DANIEL MSell257——
2026-05-07HOOLEY JOSEPH LBuy158——
2026-05-07HOOLEY JOSEPH LSell158——
2026-04-30HOOLEY JOSEPH LBuy43$560.8024.11K
2026-03-03Underberg Sharon E.Buy197$505.5399.59K
2026-03-03Underberg Sharon E.Sell197$505.5399.59K
2026-03-03Hunt NimrataSell1.76K$634.571.12M
2026-02-27MAZELSKY JONATHAN JAYBuy197$505.5399.59K
2026-02-27MAZELSKY JONATHAN JAYSell197$505.5399.59K
2026-02-26MAZELSKY JONATHAN JAYBuy23.33K$141.603.30M
2026-02-26MAZELSKY JONATHAN JAYSell1.28K$650.67833.51K
2026-02-26MAZELSKY JONATHAN JAYSell1.09K$651.49713.38K
2026-02-26MAZELSKY JONATHAN JAYSell1.67K$652.491.09M
2026-02-26MAZELSKY JONATHAN JAYSell1.17K$653.68765.45K
2026-02-26MAZELSKY JONATHAN JAYSell1.11K$654.63727.29K
2026-02-26MAZELSKY JONATHAN JAYSell1.49K$655.85975.90K
2026-02-26MAZELSKY JONATHAN JAYSell1.34K$656.85882.14K
2026-02-26MAZELSKY JONATHAN JAYSell2.86K$657.841.88M
2026-02-26MAZELSKY JONATHAN JAYSell3.66K$658.922.41M
2026-02-26MAZELSKY JONATHAN JAYSell2.86K$659.751.89M
2026-02-26MAZELSKY JONATHAN JAYSell1.20K$661.10793.32K
2026-02-26MAZELSKY JONATHAN JAYSell1.00K$662.16662.16K
2026-02-26MAZELSKY JONATHAN JAYSell2.59K$663.041.72M
2026-02-26MAZELSKY JONATHAN JAYSell23.33K$141.603.30M
2026-02-26Hunt NimrataSell2.69K$661.541.78M
2026-02-19Erickson Michael GBuy197$505.5399.59K
2026-02-19Erickson Michael GBuy183$544.0899.57K
2026-02-19Erickson Michael GBuy483$206.9499.95K
2026-02-19Erickson Michael GBuy817$178.26145.64K
2026-02-19Erickson Michael GBuy719$141.60101.81K
2026-02-19Erickson Michael GSell197$505.5399.59K
2026-02-19Erickson Michael GSell183$544.0899.57K
2026-02-19Erickson Michael GSell483$206.9499.95K
2026-02-19Erickson Michael GSell817$178.26145.64K
2026-02-19Erickson Michael GSell719$141.60101.81K
2026-02-17Erickson Michael GBuy4.18K$178.26745.13K
2026-02-17Erickson Michael GSell456$623.76284.43K
2026-02-17Erickson Michael GSell204$625.24127.55K
2026-02-17Erickson Michael GSell1.29K$626.26806.62K
2026-02-17Erickson Michael GBuy1.19K$141.60168.65K
2026-02-17Erickson Michael GSell2.69K$628.221.69M
2026-02-17Erickson Michael GSell689$629.09433.44K
2026-02-17Erickson Michael GSell40$629.8625.19K
2026-02-17Erickson Michael GSell4.18K$178.26745.13K
2026-02-17Erickson Michael GSell1.19K$141.60168.65K
2026-02-17Vandebroek Sophie V.Buy945$333.90315.54K
2026-02-17Vandebroek Sophie V.Sell945$628.65594.07K
2026-02-17Vandebroek Sophie V.Sell519$628.56326.22K
2026-02-17Vandebroek Sophie V.Sell945$333.90315.54K
2026-02-14Underberg Sharon E.Buy265——
2026-02-14Underberg Sharon E.Sell251$629.35157.97K
2026-02-14Underberg Sharon E.Buy218——
2026-02-14Underberg Sharon E.Buy176——
2026-02-14Underberg Sharon E.Buy173——
2026-02-14Underberg Sharon E.Sell265——
2026-02-14Underberg Sharon E.Sell218——
2026-02-14Underberg Sharon E.Sell176——
2026-02-14Underberg Sharon E.Sell173——
2026-02-14Smith Martin AlexanderBuy367——
2026-02-14Smith Martin AlexanderSell302$629.35190.06K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.33K, holders -14 vs prior quarter. Ownership 93.73%.

HolderSharesChangeChange %Value
BLACKROCK, INC.8.17M-195.38K-2.34%4.30B
VANGUARD CAPITAL MANAGEMENT LLC5.15M-30.29K-0.58%2.71B
VANGUARD PORTFOLIO MANAGEMENT LLC3.90M-14.34K-0.37%2.05B
STATE STREET CORP3.75M74.47K+2.03%1.97B
INVESCO LTD.3.61M1.94M+116.11%1.90B
GEODE CAPITAL MANAGEMENT, LLC2.56M-98.11K-3.69%1.35B
BAMCO INC /NY/1.98M343.41K+21.02%1.04B
MORGAN STANLEY1.36M40.15K+3.05%713.91M
BANK OF NEW YORK MELLON CORP1.19M-311.19K-20.68%628.22M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.07M228.24K+27.21%561.75M
FUNDSMITH LLP1.02M-445.90K-30.42%536.91M
BLAIR WILLIAM & CO/IL918.56K-27.78K-2.94%483.56M
NORTHERN TRUST CORP918.14K6.24K+0.68%483.34M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC911.49K39.70K+4.55%479.84M
FMR LLC822.64K539.67K+190.71%433.07M
AMERICAN CENTURY COMPANIES INC808.36K208.43K+34.74%425.55M
CAPITAL RESEARCH GLOBAL INVESTORS789.11K7.77K+0.99%415.47M
JPMORGAN CHASE & CO755.79K-24.09K-3.09%405.05M
PRINCIPAL FINANCIAL GROUP INC743.25K-137.94K-15.65%391.30M
GOLDMAN SACHS GROUP INC738.71K21.79K+3.04%388.89M
WELLINGTON MANAGEMENT GROUP LLP726.70K-8.78K-1.19%382.56M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.650.43K650.43KNew342.41M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC650.43K40.21K+6.59%342.41M
LEGAL & GENERAL GROUP PLC617.20K-33.61K-5.16%324.92M
DIMENSIONAL FUND ADVISORS LP608.90K35.57K+6.20%320.59M

Insights

Revenue by product
PeriodValue
FY2012Feline Insulin Product: 3500000.0
FY2013Cag Segment: 974004000.0
FY2014Cag Segment: 1053410000.0
FY2015Cag Segment: 1146527000.0
FY2016Cag Segment: 1281262000.0
FY2017Rapid Assay Products: 205309000.0
FY2018Extended Warranties And Post Contract Support: 27700000.0, Instrument Rebate Programs: 18200000.0, Reagent Rental Programs: 49600000.0, Up Front Customer Loyalty Programs And Volume Commitment Programs: 1300000000.0
FY2019Extended Warranties And Post Contract Support: 24400000.0, Instrument Rebate Programs: 18100000.0, Reagent Rental Programs: 31600000.0, Up Front Customer Loyalty Programs And Volume Commitment Programs: 1900000000.0
FY2020Extended Warranties And Post Contract Support: 22000000.0, Instrument Rebate Programs: 16300000.0, Reagent Rental Programs: 24800000.0, Up Front Customer Loyalty Programs And Volume Commitment Programs: 2200000000.0
FY2021Extended Warranties And Post Contract Support: 23100000.0, Instrument Rebate Programs: 14300000.0, Reagent Rental Programs: 38300000.0, Up Front Customer Loyalty Programs And Volume Commitment Programs: 2900000000.0
FY2022Extended Warranties And Post Contract Support: 21300000.0, Instrument Rebate Programs: 12000000.0, Reagent Rental Programs: 42800000.0, Up Front Customer Loyalty Programs And Volume Commitment Programs: 3200000000.0
FY2023Product: 2089936000.0, Service: 1571017000.0
FY2024Product: 2248178000.0, Service: 1649326000.0
FY2025Product: 2539210000.0, Service: 1764492000.0
Revenue by region
PeriodValue
FY2018Asia Pacific: 294956000.0, CANADA: 94206000.0, EMEA: 472070000.0, Latin America: 50969000.0, UNITED STATES: 1357909000.0
FY2019Asia Pacific: 317943000.0, CANADA: 99550000.0, EMEA: 498439000.0, Latin America: 56515000.0, UNITED STATES: 1495516000.0
FY2020Asia Pacific: 361611000.0, CANADA: 107398000.0, EMEA: 562765000.0, Latin America: 51863000.0, UNITED STATES: 1691224000.0
FY2021Asia Pacific: 420901000.0, CANADA: 139727000.0, EMEA: 681949000.0, Latin America: 66623000.0, UNITED STATES: 1995683000.0
FY2022Asia Pacific: 319553000.0, CANADA: 142743000.0, EMEA: 647034000.0, Latin America: 75035000.0, UNITED STATES: 2182959000.0
FY2023Asia Pacific: 423416000.0, CANADA: 150110000.0, EMEA: 716184000.0, Latin America: 83923000.0, UNITED STATES: 2391427000.0
FY2024Asia Pacific: 321024000.0, CANADA: 152885000.0, EMEA: 806731000.0, Latin America: 83690000.0, UNITED STATES: 2533174000.0
FY2025Asia Pacific: 355929000.0, CANADA: 167325000.0, EMEA: 937252000.0, Europe, the Middle East, and Africa, Other: 230031000.0, Latin America: 90411000.0, UNITED STATES: 2752785000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

IDEXX Laboratories (IDXX) Stock Insights

IDXX$564.88+3.63 +0.65%

$44.50B

Market Cap

40.04

P/E

38.24

Forward P/E

53

Score

Price History